Neil Desai, M.D.
Director of Clinical Research, Radiation Oncology
Associate Professor
Endowed Title Dedman Family Scholar in Clinical Care
School Medical School
Department Radiation Oncology
You have reached the Academic Profile.
For more information on the doctor and patient care, please visit the clinical profile.
View Clinical Profile
Education
- Medical School
- Yale University School of Medicine (2010)
- Internship
- Memorial Sloan-Kettering Cancer Center (2011), Transitional Year
- Residency
- Memorial Sloan Kettering Cancer Center (2015), Radiation Oncology
Research Interest
- Bladder cancer
- Prostate cancer
Publications
- Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy
- Liang X, Yen A, Bai T, Godley A, Shen C, Wu J, Meng B, Lin MH, Medin P, Yan Y, Owrangi A, Desai N, Hannan R, Garant A, Jiang S, Deng J Medical physics 2023 Dec 50 7368-7382
- Prostate Cancer, Version 4.2023
- Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D’Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Shead DA, Snedeker J, Freedman-Cass DA JNCCN Journal of the National Comprehensive Cancer Network 2023 Oct 21 1067-1096
- Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator
- Lee HH, Chiu TD, Hrycushko B, Xiong Z, Hudak S, Woldu S, Mauck R, Corwin T, Meng X, Margulis V, Desai N, Folkert MR, Garant A Brachytherapy 2023 Sep 22 580-585
- Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes
- Grossman CE, Folkert MR, Lobaugh S, Desai NB, Kollmeier MA, Gorovets D, McBride SM, Timmerman RD, Zhang Z, Zelefsky MJ Advances in Radiation Oncology 2023 Jul 8
- Passing the Kool-Aid Point: mRNA Expression–Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making
- Desai NB, Dal Pra A, Chua ML, Berlin A International Journal of Radiation Oncology Biology Physics 2023 Jul 116 530-532
- Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa
- Morgan HE, Wang K, Yan Y, Desai N, Hannan R, Chambers E, Cai B, Lin MH, Sher DJ, Wang J, Wang AZ, Jiang S, Timmerman R, Park C“, Garant A Practical Radiation Oncology 2023 Jul 13 e345-e353
- Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?
- Patel AM, West L, Atluri PS, Yi SF, Rizvi S, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199
- Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer after Radical Prostatectomy: The SALV-ENZA Trial
- Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JW, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, Denmeade S, Carducci M, Eisenberger M, Deweese TL, Orton M, Deville C, Davicioni E, Liauw SL, Heath EI, Greco S, Desai NB, Spratt DE, Feng F, Wang H, Beer TM, Antonarakis ES Journal of Clinical Oncology 2023 Feb 41 1307-1317
- NCCN GUIDELINES® INSIGHTS: Prostate Cancer, Version 1.2023: Featured Updates to the NCCN Guidelines
- Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, Bryce A, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Netto G, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Teply BA, Tward J, Valicenti R, Wong JK, Berardi RA, Shead DA, Freedman-Cass DA JNCCN Journal of the National Comprehensive Cancer Network 2022 Dec 20 1288-1298
- Enrichment of “Cribriform” morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer
- Shah RB, Palsgrove DN, Desai NB, Gagan J, Mennie A, Raj G, Hannan R Modern Pathology 2022 Oct 35 1468-1474